Tumour necrosis factor and lymphotoxin A polymorphism: A relationship with COPD and its progression?

European Respiratory Journal

Volumn 29, Issue 1, 2007, Pages 8-10

  Boezen, H M ^a   Postma, D S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; EDITORIAL; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION;

ASIAN CONTINENTAL ANCESTRY GROUP; CANADA; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LYMPHOTOXIN-ALPHA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846191549     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00144306     Document Type: Editorial

References (21)

1. Tanaka G, Sandford AJ, Burkett K, et al. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007; 29: 34-41.
2. Sandford AJ, Chagani T, Weis TD, Connett E, Anthonisen NR, Pare PD. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001; 163: 469-473.
3. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 2005; 366: 1223-1234.
4. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005; 172: 329-333.
5. van Diemen CC, Postma DS, Boezen HM. Polymorphisms in MMPs and accelerated decline in FEV1 in the general population. Proc Am Thorac Soc 2006; 3: A543.
6. Connett JE, Murray RP, Buist AS, et al. Lung Health Study Research Group Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 2003; 157: 973-979.
7. Sakao S, Tatsumi K, Igari H, et al. Association of tumor necrosis factor-α gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 2002; 122: 416-420.
8. Keatings VM, Cave SJ, Henry MJ, et al. A polymorphism in the tumor necrosis factor-α gene promoter region may predispose to a poor prognosis in COPD. Chest 2000; 118: 971-975.
9. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-α gene promoter polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 281-284.
10. Ruse CE, Hill MC, Tobin M, et al, Tumour necrosis factor gene complex polymorphisms in chronic obstructive pulmonary disease. Respir Med 2006; [Epub ahead of print PMID: 16867312].
11. Patuzzo C, Gile LS, Zorzetto M, et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 17: 1353-1358.
12. Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 2006; 27: 682-688.
13. Ferrarotti I, Zorzetto M, Beccaria M, et al. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J 2003; 21: 444-449.
14. Kucukaycan M, Van Krugten M, Pennings HJ, et al. Tumor necrosis factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 2002; 3: 29.
15. Matheson MC, Ellis JA, Raven J, Walters EH, Abramson MJ. Association of IL8, CXCR2 and TNF-α polymorphisms and airway disease. J Hum Genet 2006; 51: 196-203.
16. Jiang L, He B, Zhao MW, Ning LD, Li XY, Yao WZ. Association of gene polymorphisms of tumour necrosis factor-α and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin Med J 2005; 118: 541-547.
17. Hersh CP, DeMeo DL, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-78.
18. Chierakul N, Wongwisutikul P, Vejbaesya S, Chotvilaiwan K. Tumor necrosis factor-α gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 2005; 10: 36-39.
19. Seifart C, Dempfle A, Plagens A, et al. TNF-α-, TNF-β-, IL-6-, and IL-10 promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005; 65: 93-100.
20. Ishii T, Matsuse T, Teramoto S, et al. Neither IL-1β, IL-1 receptor antagonist, nor TNF-α polymorphisms are associated with susceptibility to COPD. Respir Med 2000; 94: 847-851.
21. Huang SL, Su CH, Chang SC Tumor necrosis factor-α gene polymorphism in chronic bronchitis, Am J Respir Crit Care Med 1997; 156: 1436-1439.